Metabolon, Inc
- PMID: 17638516
- DOI: 10.2217/14622416.8.7.863
Metabolon, Inc
Abstract
Metabolon is an emerging technology company developing proprietary analytical methods and software for biomarker discovery using metabolomics. The company's aim is to measure all small molecules (<1500 Da) in a biological sample. These small-molecule compounds include biochemicals of cellular metabolism and xenobiotics from diet and environment. Our proprietary mLIMStrade mark system contains advanced metabolomic software and automated data-processing tools that use a variety of data-analysis and quality-control algorithms to convert raw mass-spectrometry data to identified, quantitated compounds. Metabolon's primary focus is a fee-for-service business that exploits this technology for pharmaceutical and biotechnology companies, with additional clients in the consumer goods, cosmetics and agricultural industries. Fee-for-service studies are often collaborations with groups that employ a variety of technologies for biomarker discovery. Metabolon's goal is to develop technology that will automatically analyze any sample for the small-molecule components present and become a standard technology for applications in health and related sciences.
Similar articles
-
Affymetrix, Inc.Pharmacogenomics. 2002 Sep;3(5):709-11. doi: 10.1517/14622416.3.5.709. Pharmacogenomics. 2002. PMID: 12223055
-
Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.Anal Chem. 2013 Aug 6;85(15):7606-12. doi: 10.1021/ac401793d. Epub 2013 Jul 25. Anal Chem. 2013. PMID: 23845028
-
Company profile: Complete Genomics Inc.Future Oncol. 2011 Feb;7(2):219-21. doi: 10.2217/fon.10.173. Future Oncol. 2011. PMID: 21345140
-
The application of next-generation sequencing technologies to drug discovery and development.Drug Discov Today. 2011 Jun;16(11-12):512-9. doi: 10.1016/j.drudis.2011.03.006. Epub 2011 Apr 1. Drug Discov Today. 2011. PMID: 21440664 Review.
-
Knowledge discovery in metabolomics: an overview of MS data handling.J Sep Sci. 2010 Feb;33(3):290-304. doi: 10.1002/jssc.200900609. J Sep Sci. 2010. PMID: 20087872 Review.
Cited by
-
Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.Circ Heart Fail. 2014 Jul;7(4):634-42. doi: 10.1161/CIRCHEARTFAILURE.114.001151. Epub 2014 Apr 24. Circ Heart Fail. 2014. PMID: 24762972 Free PMC article.
-
Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes.Sci Rep. 2018 Sep 14;8(1):13853. doi: 10.1038/s41598-018-32085-y. Sci Rep. 2018. PMID: 30217994 Free PMC article.
-
Assessing the Protective Metabolome Using Machine Learning in World Trade Center Particulate Exposed Firefighters at Risk for Lung Injury.Sci Rep. 2019 Sep 3;9(1):11939. doi: 10.1038/s41598-019-48458-w. Sci Rep. 2019. PMID: 31481674 Free PMC article.
-
The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis.Lipids Health Dis. 2024 Feb 7;23(1):39. doi: 10.1186/s12944-024-02035-x. Lipids Health Dis. 2024. PMID: 38326855 Free PMC article.
-
G9a Modulates Lipid Metabolism in CD4 T Cells to Regulate Intestinal Inflammation.Gastroenterology. 2023 Feb;164(2):256-271.e10. doi: 10.1053/j.gastro.2022.10.011. Epub 2022 Oct 20. Gastroenterology. 2023. PMID: 36272457 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources